PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH‐RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO | Publicación